Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03239392
Title A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bioniz Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 10101 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
The James Cancer Center, Ohio State University Columbus Ohio 43210 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field